Streetbeat News

Products Services

BWA

BorgWarner Inc (NYSE:BWA) announced the next phase of its 'Charging Forward' strategy, aiming to achieve $10 billion in eProducts sales by 2027, making up nearly 50% of its total sales. The company seeks to deliver 7% margins and positive free cash flow in its eProduct portfolio by 2027.

Portfolio Pulse from Shivani Kumaresan

June 06, 2023 | 2:12 pm

AAPL

Apple TV+ has greenlit a docuseries on soccer star Lionel Messi, according to a Deadline report. The series will focus on Messi's life and career, providing exclusive access to the athlete.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 2:08 pm

HUMBF

Humble & Fume Inc. has entered into a partnership with EvoLife, manufacturer of the LocalsOnly Concentrate brand of cannabis products. Humble will be responsible for the exclusive distribution and sales of EvoLife's entire catalog, ensuring a wider audience for the products.

Portfolio Pulse from Vuk Zdinjak

June 06, 2023 | 2:08 pm

VRAR

The Glimpse Group President & CEO, Lyron Bentovim, will appear on Benzinga's Live YouTube TV at 11 a.m. ET to discuss the company and its prospects.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:53 pm

GSK

The FDA has accepted GSK's supplemental marketing application for Jemperli (dostarlimab) in combination with chemotherapy for the treatment of adult patients with advanced or recurrent endometrial cancer. The FDA granted Priority Review and assigned a Prescription Drug User Fee Act action date of 23 September. Jemperli was also recently granted Breakthrough Therapy designation.

Portfolio Pulse from Vandana Singh

June 06, 2023 | 1:36 pm

BNTX

MRNA

NVAX

PFE

Novavax's R&D chief Filip Dubovsky expressed confidence in the company's updated COVID-19 vaccine targeting emerging variants. The protein-based vaccine is slower to manufacture than mRNA-based vaccines but is promising in targeting evolving strains. Novavax has initiated manufacturing a vaccine version aimed at combating the dominant XBB.1.5 variant.

Portfolio Pulse from Vandana Singh

June 06, 2023 | 1:32 pm

OKYO

OKYO Pharma has announced that the randomized segment of its Phase 2 clinical trial for topical ocular OK-101, a treatment for dry eye disease, is now underway.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:31 pm

AZN

SNY

The US FDA staff reported that Sanofi and AstraZeneca's RSV prevention antibody demonstrated a favorable safety profile in clinical trials. However, 12 deaths were reported in pediatric patients who took the therapy, with 8 of them being unrelated to the study drug.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:29 pm

AMZN

DASH

Amazon Canada and DoorDash have announced a free one-year DashPass membership for Prime members, offering benefits such as reduced service fees and free delivery on orders over $25.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:22 pm

WKEY

WISeKey announced the expansion of its satellite business into WISeSat AG, a new company based in Switzerland. This move aims to capitalize on the growing demand for satellite-based IoT and cybersecurity services.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:21 pm